These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31030294)

  • 21. Association between periodontitis and chronic migraine: a case-control study.
    Ameijeira P; Leira Y; Domínguez C; Leira R; Blanco J
    Odontology; 2019 Jan; 107(1):90-95. PubMed ID: 29651667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of Migraineurs Having Allodynia: Results of a Large Population-based Study.
    Baykan B; Ekizoglu E; Karli N; Kocasoy-Orhan E; Zarifoglu M; Saip S; Siva A; Ertas M
    Clin J Pain; 2016 Jul; 32(7):631-5. PubMed ID: 26379076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of depressive symptoms with allodynia in patients with migraine: A cross-sectional study.
    Mendonça MD; Caetano A; Viana-Baptista M;
    Cephalalgia; 2016 Oct; 36(11):1077-1081. PubMed ID: 26634832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with triptan use in episodic migraine: results from the American Migraine Prevalence and Prevention Study.
    Chu MK; Buse DC; Bigal ME; Serrano D; Lipton RB
    Headache; 2012 Feb; 52(2):213-23. PubMed ID: 22413150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-world treatment patterns and patient-reported outcomes in episodic and chronic migraine in Japan: analysis of data from the Adelphi migraine disease specific programme.
    Ueda K; Ye W; Lombard L; Kuga A; Kim Y; Cotton S; Jackson J; Treuer T
    J Headache Pain; 2019 Jun; 20(1):68. PubMed ID: 31174464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Panic disorder and migraine: comorbidity, mechanisms, and clinical implications.
    Smitherman TA; Kolivas ED; Bailey JR
    Headache; 2013 Jan; 53(1):23-45. PubMed ID: 23278473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insufficient sleep is prevalent among migraineurs: a population-based study.
    Kim J; Cho SJ; Kim WJ; Yang KI; Yun CH; Chu MK
    J Headache Pain; 2017 Dec; 18(1):50. PubMed ID: 28455722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Similarities and differences between chronic migraine and episodic migraine.
    Ferrari A; Leone S; Vergoni AV; Bertolini A; Sances G; Coccia CP; Ottani A; Pinetti D; Sternieri E
    Headache; 2007 Jan; 47(1):65-72. PubMed ID: 17355496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Symptoms of premenstrual syndrome in female migraineurs with and without menstrual migraine.
    Vetvik KG; MacGregor EA; Lundqvist C; Russell MB
    J Headache Pain; 2018 Oct; 19(1):97. PubMed ID: 30332985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB; Munjal S; Buse DC; Fanning KM; Bennett A; Reed ML
    Headache; 2016 Nov; 56(10):1635-1648. PubMed ID: 27731896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sleep disturbances and quality of life in Sub-Saharan African migraineurs.
    Morgan I; Eguia F; Gelaye B; Peterlin BL; Tadesse MG; Lemma S; Berhane Y; Williams MA
    J Headache Pain; 2015 Mar; 16():18. PubMed ID: 25902831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Asthma is a risk factor for new onset chronic migraine: Results from the American migraine prevalence and prevention study.
    Martin VT; Fanning KM; Serrano D; Buse DC; Reed ML; Lipton RB
    Headache; 2016 Jan; 56(1):118-31. PubMed ID: 26581563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychiatric comorbidities in allodynic migraineurs.
    Kao CH; Wang SJ; Tsai CF; Chen SP; Wang YF; Fuh JL
    Cephalalgia; 2014 Mar; 34(3):211-8. PubMed ID: 24048892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous Allodynia and Its Risk Factors in Korean Patients with Migraine: A Survey of Two Tertiary Care Hospitals.
    Kim SY; Park SP
    J Oral Facial Pain Headache; 2016 Fall; 30(4):323-329. PubMed ID: 27792800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triggers in allodynic and non-allodynic migraineurs. A clinic setting study.
    Baldacci F; Vedovello M; Ulivi M; Vergallo A; Poletti M; Borelli P; Cipriani G; Nuti A; Bonuccelli U
    Headache; 2013 Jan; 53(1):152-160. PubMed ID: 23278553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine.
    Silberstein SD; Lee L; Gandhi K; Fitzgerald T; Bell J; Cohen JM
    Headache; 2018 Nov; 58(10):1579-1592. PubMed ID: 30375650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey.
    MacGregor EA; Brandes J; Eikermann A
    Headache; 2003 Jan; 43(1):19-26. PubMed ID: 12864754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association Between Migraine and Suicidal Behaviors: A Nationwide Study in the USA.
    Friedman LE; Zhong QY; Gelaye B; Williams MA; Peterlin BL
    Headache; 2018 Mar; 58(3):371-380. PubMed ID: 29193052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Real-World Analysis of Migraine: A Cross-Sectional Study of Disease Burden and Treatment Patterns.
    Ford JH; Jackson J; Milligan G; Cotton S; Ahl J; Aurora SK
    Headache; 2017 Nov; 57(10):1532-1544. PubMed ID: 28984356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Has the prevalence of migraine changed over the last decade (2003-2012)? A Spanish population-based survey.
    Fernández-de-las-Peñas C; Palacios-Ceña D; Salom-Moreno J; López-de-Andres A; Hernández-Barrera V; Jiménez-Trujillo I; Jiménez-García R; Gallardo-Pino C; García-Gómez-de-las-Heras MS; Carrasco-Garrido P
    PLoS One; 2014; 9(10):e110530. PubMed ID: 25343495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.